pimozide has been researched along with Adenocarcinoma Of Kidney in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YR; Hur, K; Kim, G; Kim, S; Kwon, TK; Park, JW; Seo, SU; Woo, SM | 1 |
1 other study(ies) available for pimozide and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Deubiquitinating Enzymes; Down-Regulation; Humans; Kidney Neoplasms; Mice; MicroRNAs; Pimozide; Proliferating Cell Nuclear Antigen; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; Survivin; Ubiquitin-Specific Proteases; Ubiquitins; Up-Regulation | 2022 |